Quest for success: Innovative strategies to accelerate bispecific antibody productionAvailable on-demand
Preclinical evidence of IGF1R/IR pathway inhibition in combination with GD2-CAR T-cells as a potent therapeutic strategy for diffuse midline glioma H3K27M mutantAvailable on-demand
